KORU Medical Systems, Inc.
How the company evolved, year by year. Revenue and debt come from the annual reports — for most companies, the 10-K filings with the SEC since 2009; dividends from the payments themselves.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Major managers that reported this stock in their latest 13F.
▲ +28.9% over 5Y.
today you would have $1,126.32▲ +12.6%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
The last 15 closed years. Each multiple uses that year’s closing price and that year’s reported numbers — not today’s. The range is set by the annual reports on record.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Year-end price | $5.81 | $3.85 | $2.45 | $3.57 | $3.00 | $6.02 | $6.53 | $1.65 | $1.25 | $0.50 | $0.55 | $0.47 | $0.22 | $0.23 | $0.26 | |
| P/E | 23.5x | — | — |
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| IMUXImmunic Inc | $10.84 | — | 1.2x | — | -138.17% | $147.91M |
| QTRXQuanterix Corp | $3.16 | — | 0.6x | — | -46.48% | $149.45M |
| WWWW International Inc | $15.03 | 1.4x | 0.5x | — | -30.71% | $150.28M |
| NMRANeumora Therapeutics, Inc. | $0.78 |
KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the FREEDOM infusion systems to deliver therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating polyneuropathy (CIDP), secondary immunodeficiency disorder (SIDD), and paroxysmal nocturnal hemoglobinuria (PNH). Its products include the FREEDOM60 Syringe Driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company was formerly known as Repro Med Systems, Inc. and changed its name to KORU Medical Systems, Inc. in March 2022. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Mahwah, New Jersey.
Company description provided by Yahoo Finance.
| — |
| — |
| — |
| — |
| 653.0x |
| 82.5x |
| — |
| 25.0x |
| 27.5x |
| 23.5x |
| 10.9x |
| 11.5x |
| 13.0x |
| P/S | 3.8x | 6.6x | 5.3x | 3.9x | 5.8x | 5.7x | 11.1x | 11.2x | 3.6x | 3.8x | 1.5x | 1.9x | 2.0x | 1.0x | 1.3x | 1.8x |
| P/B | 5.2x | 15.8x | 10.5x | 5.5x | 5.2x | 3.7x | 7.4x | 23.1x | 7.0x | 7.1x | 2.7x | 3.3x | 3.3x | 1.8x | 2.3x | 3.6x |
| EPS | -$0.06 | -$0.13 | -$0.30 | -$0.19 | -$0.10 | -$0.03 | $0.01 | $0.02 | -$0.01 | $0.02 | $0.02 | $0.02 | $0.02 | $0.02 | $0.02 |
| Profit margin | 2.44% | -6.41% | -18.03% | -48.18% | -31.05% | -19.42% | -5.01% | 2.44% | 5.25% | -4.35% | 6.39% | 6.70% | 8.09% | 9.35% | 12.77% | 14.31% |
| ROE | 5.02% | -15.47% | -36.08% | -67.51% | -27.65% | -12.50% | -3.35% | 5.02% | 10.16% | -8.01% | 11.00% | 12.00% | 13.55% | 16.66% | 22.98% | 28.39% |
Median, not average: a single year of near-zero profit produces a P/E of 400 and would drag an average on its own. P/E years above 200x are left out, the same cut the fair price uses — so this median matches the “its own history” method below. Price and EPS have no median: they are series that grow.
| — |
| 3.3x |
| — |
| -187.11% |
| $146.28M |
| OWLTOwlet, Inc. | $4.99 | — | 6.2x | — | — | $145.82M |
| CDXSCodexis Inc | $1.38 | — | 3.8x | — | -69.36% | $151.12M |